RUNX1 and acute myeloid leukemia: Therefore, the inability of RUNX1 mutations to induce clonal HSC expansion like that seen with DNMT3A and TET2 mutations may account for the rarity of RUNX1 mutations as initiating events in AML and in CHIP.